Wegovy News

GLP-1 Weight-Loss Pills: What You Need to Know - Yale Medicine

GLP-1 Weight-Loss Pills: What You Need to Know Yale Medicine

Foundayo, Wegovy and how GLP-1 weight-loss pills compare to shots - USA Today

Foundayo, Wegovy and how GLP-1 weight-loss pills compare to shots USA Today

Maine doctor reacts to new GLP-1 pill by Wegovy - WMTW

Maine doctor reacts to new GLP-1 pill by Wegovy WMTW

Novo Nordisk launches higher-dose Wegovy in the United States - Reuters

Novo Nordisk launches higher-dose Wegovy in the United States Reuters

The FDA approves a new obesity pill, giving patients another option - NPR

The FDA approves a new obesity pill, giving patients another option NPR

What Is 'Eye Stroke'? Expert Explains The Rare Wegovy Risk - ScienceAlert

What Is 'Eye Stroke'? Expert Explains The Rare Wegovy Risk ScienceAlert

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals. - Business Insider

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals. Business Insider

Ozempic Is About to Go Generic for Billions of People - The New York Times

Ozempic Is About to Go Generic for Billions of People The New York Times

Weight-loss jabs will be offered on NHS for people at risk of further heart attacks - BBC

Weight-loss jabs will be offered on NHS for people at risk of further heart attacks BBC

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval - Scientific American

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval Scientific American

How do weight-loss drugs like Mounjaro and Wegovy work? - BBC

How do weight-loss drugs like Mounjaro and Wegovy work? BBC

Comparison of Oral Semaglutide (Wegovy) and Orforglipron (Foundayo) for the Treatment of Obesity and Overweight - Medical Professionals Reference

Comparison of Oral Semaglutide (Wegovy) and Orforglipron (Foundayo) for the Treatment of Obesity and Overweight Medical Professionals Reference

Novo Nordisk's Wegovy® HD available now nationwide - PR Newswire

Novo Nordisk's Wegovy® HD available now nationwide PR Newswire

EXCLUSIVE: New Subscription Program for Wegovy Could Save Patients $1,200 a Year — How to Access It - TODAY.com

EXCLUSIVE: New Subscription Program for Wegovy Could Save Patients $1,200 a Year — How to Access It TODAY.com

Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment - CNBC

Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment CNBC

The new high dose of Wegovy costs less than Zepbound - MarketWatch

The new high dose of Wegovy costs less than Zepbound MarketWatch

Novo Nordisk Launches Higher-Dose Wegovy Weight-Loss Shot in U.S. - WSJ

Novo Nordisk Launches Higher-Dose Wegovy Weight-Loss Shot in U.S. WSJ

FDA approves Foundayo, an oral GLP-1 alternative to Wegovy - Medical News Today

FDA approves Foundayo, an oral GLP-1 alternative to Wegovy Medical News Today

BMO cuts Novo Nordisk stock price target on Wegovy Pill revenue concerns - Investing.com

BMO cuts Novo Nordisk stock price target on Wegovy Pill revenue concerns Investing.com

Wegovy Launches New Subscription—How to Save Up to $1,200 - Forbes

Wegovy Launches New Subscription—How to Save Up to $1,200 Forbes

FDA Approves Foundayo, a Wegovy Alternative GLP-1 Pill for Weight Loss - Healthline

FDA Approves Foundayo, a Wegovy Alternative GLP-1 Pill for Weight Loss Healthline

America Has a New GLP-1 Playbook - The Atlantic

America Has a New GLP-1 Playbook The Atlantic

Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year - PR Newswire

Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year PR Newswire

FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile - PR Newswire

FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile PR Newswire